ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Asthma Reliever (Rescue) Medications Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-3R10710
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Asthma Reliever Rescue Medications Market Research Report 2022
BUY CHAPTERS

Global Asthma Reliever (Rescue) Medications Market Research Report 2025

Code: QYRE-Auto-3R10710
Report
March 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dulera
QVAR
GlaxoSmithKline PLC
MAP Pharmaceuticals，Inc
Merck& Co. Inc
Astrazeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi Aventis
Theravance Inc

Asthma Reliever (Rescue) Medications Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Asthma Reliever (Rescue) Medications Market

Asthma Reliever (Rescue) Medications Market

The global market for Asthma Reliever (Rescue) Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Asthma Reliever (Rescue) Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Reliever (Rescue) Medications.
The Asthma Reliever (Rescue) Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Asthma Reliever (Rescue) Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Reliever (Rescue) Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Asthma Reliever (Rescue) Medications Market Report

Report Metric Details
Report Name Asthma Reliever (Rescue) Medications Market
CAGR 5%
Segment by Type
  • Quick-Relief Medications
  • Long-Term Control Medications
Segment by Application
  • Children
  • Adolescent
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Asthma Reliever (Rescue) Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Asthma Reliever (Rescue) Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Asthma Reliever (Rescue) Medications Market report?

Ans: The main players in the Asthma Reliever (Rescue) Medications Market are Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc

What are the Application segmentation covered in the Asthma Reliever (Rescue) Medications Market report?

Ans: The Applications covered in the Asthma Reliever (Rescue) Medications Market report are Children, Adolescent, Adult

What are the Type segmentation covered in the Asthma Reliever (Rescue) Medications Market report?

Ans: The Types covered in the Asthma Reliever (Rescue) Medications Market report are Quick-Relief Medications, Long-Term Control Medications

1 Asthma Reliever (Rescue) Medications Market Overview
1.1 Product Definition
1.2 Asthma Reliever (Rescue) Medications by Type
1.2.1 Global Asthma Reliever (Rescue) Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.3 Asthma Reliever (Rescue) Medications by Application
1.3.1 Global Asthma Reliever (Rescue) Medications Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Global Asthma Reliever (Rescue) Medications Market Size Estimates and Forecasts
1.4.1 Global Asthma Reliever (Rescue) Medications Revenue 2020-2031
1.4.2 Global Asthma Reliever (Rescue) Medications Sales 2020-2031
1.4.3 Global Asthma Reliever (Rescue) Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Asthma Reliever (Rescue) Medications Market Competition by Manufacturers
2.1 Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Asthma Reliever (Rescue) Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Asthma Reliever (Rescue) Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Product Type & Application
2.7 Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Date of Enter into This Industry
2.8 Global Asthma Reliever (Rescue) Medications Market Competitive Situation and Trends
2.8.1 Global Asthma Reliever (Rescue) Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Asthma Reliever (Rescue) Medications Players Market Share by Revenue
2.8.3 Global Asthma Reliever (Rescue) Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Asthma Reliever (Rescue) Medications Market Scenario by Region
3.1 Global Asthma Reliever (Rescue) Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Asthma Reliever (Rescue) Medications Sales by Region: 2020-2031
3.2.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2020-2025
3.2.2 Global Asthma Reliever (Rescue) Medications Sales by Region: 2026-2031
3.3 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2020-2031
3.3.1 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2020-2025
3.3.2 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2026-2031
3.4 North America Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.4.1 North America Asthma Reliever (Rescue) Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Asthma Reliever (Rescue) Medications Sales by Country (2020-2031)
3.4.3 North America Asthma Reliever (Rescue) Medications Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.5.1 Europe Asthma Reliever (Rescue) Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Asthma Reliever (Rescue) Medications Sales by Country (2020-2031)
3.5.3 Europe Asthma Reliever (Rescue) Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Reliever (Rescue) Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Asthma Reliever (Rescue) Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.7.1 Latin America Asthma Reliever (Rescue) Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Asthma Reliever (Rescue) Medications Sales by Country (2020-2031)
3.7.3 Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Reliever (Rescue) Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2020-2031)
4.1.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2020-2025)
4.1.2 Global Asthma Reliever (Rescue) Medications Sales by Type (2026-2031)
4.1.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2020-2031)
4.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2020-2031)
4.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Type (2020-2025)
4.2.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2026-2031)
4.2.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2020-2031)
4.3 Global Asthma Reliever (Rescue) Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2020-2031)
5.1.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2020-2025)
5.1.2 Global Asthma Reliever (Rescue) Medications Sales by Application (2026-2031)
5.1.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2020-2031)
5.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2020-2031)
5.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Application (2020-2025)
5.2.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2026-2031)
5.2.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2020-2031)
5.3 Global Asthma Reliever (Rescue) Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dulera
6.1.1 Dulera Company Information
6.1.2 Dulera Description and Business Overview
6.1.3 Dulera Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dulera Asthma Reliever (Rescue) Medications Product Portfolio
6.1.5 Dulera Recent Developments/Updates
6.2 QVAR
6.2.1 QVAR Company Information
6.2.2 QVAR Description and Business Overview
6.2.3 QVAR Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 QVAR Asthma Reliever (Rescue) Medications Product Portfolio
6.2.5 QVAR Recent Developments/Updates
6.3 Glaxosmithkline plc
6.3.1 Glaxosmithkline plc Company Information
6.3.2 Glaxosmithkline plc Description and Business Overview
6.3.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio
6.3.5 Glaxosmithkline plc Recent Developments/Updates
6.4 MAP Pharmaceuticals，Inc
6.4.1 MAP Pharmaceuticals，Inc Company Information
6.4.2 MAP Pharmaceuticals，Inc Description and Business Overview
6.4.3 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.4.5 MAP Pharmaceuticals，Inc Recent Developments/Updates
6.5 Merck & Co. Inc
6.5.1 Merck & Co. Inc Company Information
6.5.2 Merck & Co. Inc Description and Business Overview
6.5.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.5.5 Merck & Co. Inc Recent Developments/Updates
6.6 AstraZeneca plc
6.6.1 AstraZeneca plc Company Information
6.6.2 AstraZeneca plc Description and Business Overview
6.6.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio
6.6.5 AstraZeneca plc Recent Developments/Updates
6.7 Roche Holdings Ltd
6.7.1 Roche Holdings Ltd Company Information
6.7.2 Roche Holdings Ltd Description and Business Overview
6.7.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio
6.7.5 Roche Holdings Ltd Recent Developments/Updates
6.8 Genentech Inc
6.8.1 Genentech Inc Company Information
6.8.2 Genentech Inc Description and Business Overview
6.8.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.8.5 Genentech Inc Recent Developments/Updates
6.9 Sepracor, Inc
6.9.1 Sepracor, Inc Company Information
6.9.2 Sepracor, Inc Description and Business Overview
6.9.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.9.5 Sepracor, Inc Recent Developments/Updates
6.10 Schering-Plough Corp
6.10.1 Schering-Plough Corp Company Information
6.10.2 Schering-Plough Corp Description and Business Overview
6.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio
6.10.5 Schering-Plough Corp Recent Developments/Updates
6.11 Sanofi-Aventis
6.11.1 Sanofi-Aventis Company Information
6.11.2 Sanofi-Aventis Description and Business Overview
6.11.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio
6.11.5 Sanofi-Aventis Recent Developments/Updates
6.12 Theravance Inc
6.12.1 Theravance Inc Company Information
6.12.2 Theravance Inc Description and Business Overview
6.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.12.5 Theravance Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Reliever (Rescue) Medications Industry Chain Analysis
7.2 Asthma Reliever (Rescue) Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Reliever (Rescue) Medications Production Mode & Process Analysis
7.4 Asthma Reliever (Rescue) Medications Sales and Marketing
7.4.1 Asthma Reliever (Rescue) Medications Sales Channels
7.4.2 Asthma Reliever (Rescue) Medications Distributors
7.5 Asthma Reliever (Rescue) Medications Customer Analysis
8 Asthma Reliever (Rescue) Medications Market Dynamics
8.1 Asthma Reliever (Rescue) Medications Industry Trends
8.2 Asthma Reliever (Rescue) Medications Market Drivers
8.3 Asthma Reliever (Rescue) Medications Market Challenges
8.4 Asthma Reliever (Rescue) Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Dulera
QVAR
GlaxoSmithKline PLC
MAP Pharmaceuticals，Inc
Merck& Co. Inc
Astrazeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi Aventis
Theravance Inc
List of Tables
 Table 1. Global Asthma Reliever (Rescue) Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Asthma Reliever (Rescue) Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Asthma Reliever (Rescue) Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Asthma Reliever (Rescue) Medications Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Asthma Reliever (Rescue) Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Asthma Reliever (Rescue) Medications Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Asthma Reliever (Rescue) Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Asthma Reliever (Rescue) Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Reliever (Rescue) Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Asthma Reliever (Rescue) Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Asthma Reliever (Rescue) Medications Sales by Region (2020-2025) & (K Units)
 Table 18. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Asthma Reliever (Rescue) Medications Sales by Region (2026-2031) & (K Units)
 Table 20. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Asthma Reliever (Rescue) Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Asthma Reliever (Rescue) Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Asthma Reliever (Rescue) Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Asthma Reliever (Rescue) Medications Sales by Country (2020-2025) & (K Units)
 Table 27. North America Asthma Reliever (Rescue) Medications Sales by Country (2026-2031) & (K Units)
 Table 28. North America Asthma Reliever (Rescue) Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Asthma Reliever (Rescue) Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Asthma Reliever (Rescue) Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Asthma Reliever (Rescue) Medications Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Asthma Reliever (Rescue) Medications Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Asthma Reliever (Rescue) Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Asthma Reliever (Rescue) Medications Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Asthma Reliever (Rescue) Medications Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Type (2020-2025)
 Table 51. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Type (2026-2031)
 Table 52. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Application (2020-2025)
 Table 61. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Application (2026-2031)
 Table 62. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Application (2026-2031)
 Table 70. Dulera Company Information
 Table 71. Dulera Description and Business Overview
 Table 72. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Dulera Asthma Reliever (Rescue) Medications Product
 Table 74. Dulera Recent Developments/Updates
 Table 75. QVAR Company Information
 Table 76. QVAR Description and Business Overview
 Table 77. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. QVAR Asthma Reliever (Rescue) Medications Product
 Table 79. QVAR Recent Developments/Updates
 Table 80. Glaxosmithkline plc Company Information
 Table 81. Glaxosmithkline plc Description and Business Overview
 Table 82. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product
 Table 84. Glaxosmithkline plc Recent Developments/Updates
 Table 85. MAP Pharmaceuticals，Inc Company Information
 Table 86. MAP Pharmaceuticals，Inc Description and Business Overview
 Table 87. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product
 Table 89. MAP Pharmaceuticals，Inc Recent Developments/Updates
 Table 90. Merck & Co. Inc Company Information
 Table 91. Merck & Co. Inc Description and Business Overview
 Table 92. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product
 Table 94. Merck & Co. Inc Recent Developments/Updates
 Table 95. AstraZeneca plc Company Information
 Table 96. AstraZeneca plc Description and Business Overview
 Table 97. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AstraZeneca plc Asthma Reliever (Rescue) Medications Product
 Table 99. AstraZeneca plc Recent Developments/Updates
 Table 100. Roche Holdings Ltd Company Information
 Table 101. Roche Holdings Ltd Description and Business Overview
 Table 102. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product
 Table 104. Roche Holdings Ltd Recent Developments/Updates
 Table 105. Genentech Inc Company Information
 Table 106. Genentech Inc Description and Business Overview
 Table 107. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Genentech Inc Asthma Reliever (Rescue) Medications Product
 Table 109. Genentech Inc Recent Developments/Updates
 Table 110. Sepracor, Inc Company Information
 Table 111. Sepracor, Inc Description and Business Overview
 Table 112. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sepracor, Inc Asthma Reliever (Rescue) Medications Product
 Table 114. Sepracor, Inc Recent Developments/Updates
 Table 115. Schering-Plough Corp Company Information
 Table 116. Schering-Plough Corp Description and Business Overview
 Table 117. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product
 Table 119. Schering-Plough Corp Recent Developments/Updates
 Table 120. Sanofi-Aventis Company Information
 Table 121. Sanofi-Aventis Description and Business Overview
 Table 122. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product
 Table 124. Sanofi-Aventis Recent Developments/Updates
 Table 125. Theravance Inc Company Information
 Table 126. Theravance Inc Description and Business Overview
 Table 127. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Theravance Inc Asthma Reliever (Rescue) Medications Product
 Table 129. Theravance Inc Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Asthma Reliever (Rescue) Medications Distributors List
 Table 133. Asthma Reliever (Rescue) Medications Customers List
 Table 134. Asthma Reliever (Rescue) Medications Market Trends
 Table 135. Asthma Reliever (Rescue) Medications Market Drivers
 Table 136. Asthma Reliever (Rescue) Medications Market Challenges
 Table 137. Asthma Reliever (Rescue) Medications Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Asthma Reliever (Rescue) Medications
 Figure 2. Global Asthma Reliever (Rescue) Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Asthma Reliever (Rescue) Medications Market Share by Type: 2024 & 2031
 Figure 4. Quick-Relief Medications Product Picture
 Figure 5. Long-Term Control Medications Product Picture
 Figure 6. Global Asthma Reliever (Rescue) Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Asthma Reliever (Rescue) Medications Market Share by Application: 2024 & 2031
 Figure 8. Children
 Figure 9. Adolescent
 Figure 10. Adult
 Figure 11. Global Asthma Reliever (Rescue) Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Asthma Reliever (Rescue) Medications Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Asthma Reliever (Rescue) Medications Sales (2020-2031) & (K Units)
 Figure 14. Global Asthma Reliever (Rescue) Medications Average Price (US$/Unit) & (2020-2031)
 Figure 15. Asthma Reliever (Rescue) Medications Report Years Considered
 Figure 16. Asthma Reliever (Rescue) Medications Sales Share by Manufacturers in 2024
 Figure 17. Global Asthma Reliever (Rescue) Medications Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Asthma Reliever (Rescue) Medications Players: Market Share by Revenue in Asthma Reliever (Rescue) Medications in 2024
 Figure 19. Asthma Reliever (Rescue) Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Asthma Reliever (Rescue) Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Asthma Reliever (Rescue) Medications Sales Market Share by Country (2020-2031)
 Figure 22. North America Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Country (2020-2031)
 Figure 26. Europe Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Asthma Reliever (Rescue) Medications Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2020-2031)
 Figure 34. China Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Asthma Reliever (Rescue) Medications Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Asthma Reliever (Rescue) Medications Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Asthma Reliever (Rescue) Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Asthma Reliever (Rescue) Medications by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Asthma Reliever (Rescue) Medications by Type (2020-2031)
 Figure 56. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Asthma Reliever (Rescue) Medications by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Asthma Reliever (Rescue) Medications by Application (2020-2031)
 Figure 59. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Application (2020-2031)
 Figure 60. Asthma Reliever (Rescue) Medications Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Quick relief Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Asthma Medication Market Research Report 2025
Global Asthma Therapeutic Drug Market Research Report 2024
Global Asthma Therapeutics Market Research Report 2025
Severe Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allergic Asthma Therapeutics Market Research Report 2025
Global Asthma Clinical Therapeutic Drug Market Research Report 2025
Long term Asthma Control Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Long Term Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Emergency Care Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Asthma and COPD Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Reliever Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiallergics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptic Ulcer Relief Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions